Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients
This study is ongoing, but not recruiting participants.
Study NCT00611403   Information provided by Allergan
First Received: January 28, 2008   Last Updated: January 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dry Eye Syndromes
Additional conditions recognized in this trial
Syndrome
More general conditions related to this trial
Disease
Eye Diseases
Lacrimal Apparatus Diseases
Pathologic Processes
Interventions listed in this trial
Artificial Tears REFRESH ENDURA®
Additional drug interventions recognized in this trial
Cyclosporine
Cyclosporins
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Allergan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services